Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy.

Bu, Xiaoyun; Liu, Shuang; Wen, Dongsheng; Kan, Anna; Xu, Yujie; Lin, Xuanjia; Shi, Ming.

Afiliação

Bu X; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
Liu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Wen D; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
Kan A; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Xu Y; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
Lin X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Shi M; Department of Liver Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

Mol Ther Oncolytics ; 26: 226-244, 2022 Sep 15.

Article em En | MEDLINE | ID: mdl-35919459